Class II

Drug Recall: Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.

SCOPE HEALTH · April 20, 2026

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0499-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.